C4 is the only component of the human complement system that is coded for by two genes, C4A and C4B, showing 99% homology. The genes for the two C4 isotypes are located with the genes for the second component (C2), factor B (BF), and steroid 21-hydroxylase (21-OHA and 21-OHB) between HLA-B and -DR in the MHC on chromosome six (1-4). The C4 and 21-OH genes are tandemly arranged and have probably arisen by duplication (Fig . 1 a) . Based on the direction of transcription, C4A is usually expressed at C4 locus I, whereas C4B is usually expressed at locus II (5).
Haplotypes with the typical C4 two-gene configuration expressing two different C4A allotypes (e.g., C4A3,2 BQO), as well as a single C4A3 BQO haplotype with two C4 loci only containing specific sequences ofthe C4A isotype, have already been reported (5, (20) (21) (22) .
To further characterize the structural basis of C4 null alleles not accounted for by deletions, we studied 26 individuals homozygous either for C4AQO or for C4BQO. Haplotypes carrying null alleles not due to deletions were selected for study by genomic RFLP analysis . Using synthetic oligonucleotides, restriction fragment analysis, and direct sequencing of genomic DNA amplified by the polymerase chain reaction (23, 24) , we studied the isotype-specific sequences of the C4d region that correlate with the Rodgers and Chido determinants as defined by serology. The presence of a respective DNA sequence for a given determinant not detectable by serology would indicate the nonexpression of an allele, whereas the correlation of DNA sequence and serological findings would provide evidence for the possible expression ofboth adjacent C4 genes . Using this approach, we detected six haplotypes in which C4A genes were nonexpressed and 19 haplotypes with apparent nondeleted BQO alleles which had only C4A-specific sequences . These findings provide evidence for independent genetic mechanisms at the C4 loci resulting either in pseudogenes or in genes which, as a result of gene conversion, may express the reverse isotype .
Materials and Methods
Selection of Individuals and Genetic Typing . 26 individuals with homozygous C4A or C4B deficiency (AQO or BQO) were included . All individuals had been haplotyped for MHC class I, II, and III gene products in family studies according to the following methods : HLA-A, -B, -C, and -DR antigens were assigned by the microlymphocytotoxicity assay (25) . C4 typing was carried out by high voltage agarose gel electrophoresis in a discontinuous buffer system after desialation of the samples with neuraminidase, followed by immunofixation or hemolytic overlay (7) . C4 null alleles were confirmed by C4 a chain typing using SDS-PAGE (9) . The serological typing ofthe C4 antigenic determinants Rodgers and Chido was carried out on all C4BQO individuals by means ofhemagglutination inhibition with human alloantisera as described (10) .
DNA Probes. The C4-specific probe used for Southern blot analysis was a 400-bp Barn HI/Kpn I fragment from the Tend of the full-length C4 cDNA clone pATA (26) , and the 21-OH-specific probe was a 900-bp Bgl I/Kpn I fragment from the genomic cosmid clone cos IE3 (2) .
Southern Blot Analysis. Human genomic DNA was prepared from 10-ml blood samples (27) . DNA samples of 10 t~g were digested with Taq I at a concentration of 5 U/lig (Boehringer Mannheim, Mannheim, FRG). The DNA fragments were electrophoresed in a 0.8% agarose gel and blotted onto nitrocellulose membrane (BA 85; Schleicher & Schuell, Dassel, FRG). The C4 and 21-OH probes were radiolabeled with a-[ 32 P]dCTP (Amersham Buchler, Braunschweig, FRG) by nick translation . Hybridization of blots and interpretation of restriction fragment patterns were carried out as described previously (19) .
PCR Amplification. The polymerase chain reaction was performed as described (24) using 1 ttg genomic DNA and 2 U Taq polymerase (Cetus Corp., Emeryville, CA) . The temperature cycles were modified as follows and repeated 35 times : 2 min at 91°C (denaturing), 3 min at 55°C (annealing), 5 min at 70°C (extension) .
The primer sequences were chosen according to published C4 gene sequences (28) . The four oligonucleotide primers were as follows (cf., Detection of C4 Isotype-specific Sequences. For oligonucleotide hybridization (Fig. 1) , the amplified DNA was electrophoresed in a 1% agarose gel. After transfer to nylon membrane (Hybond N; Amersham Buehler), the blots were hybridized first with oligo A according to procedures described previously (29) . After autoradiography for 6 h, the probe was removed by boiling the blots for 20 min in 0.1% SDS and rehybridized with oligo B. Oligos A and B were endlabeled with polynucleotide kinase (Boehringer Mannheim) with y-[ 32 p]ATP (Amersham Buchler) .
For the direct analysis of restriction fragments (Fig. 2) , the amplified DNA (using PCR primers (L3/L4) was purified from PCR buffer components by adsorption to glass milk (Geneclean; BIO 101 ; La Jolla, CA), and digested with 5 U EcoO 109, with 3 U Nla IV, or with 10 U Alu I (all from New England Biolabs, Bad Schwalbach, FRG). DNA digested with Nla IV and EcoO 109 was electrophoresed in a 1.5% agarose gel . DNA digested with Alu I was separated in a 10% polyacrylamide gel, as the resulting fragments were smaller than 100 bp. The fragments were visualized on a UV light box at 312 nm after ethidiumbromide staining.
DNA Sequencing.
For direct sequencing of PCRamplified genomic DNA, the amplified DNA fragment was purified by agarose gel electrophoresis followed by electroelution to remove the PCR primers . The eluted template DNA was further purified by adsorption to glass milk (see above) . The sequencing reaction was carried out following a protocol for doublestranded DNA with the SequenaseTM sequencing system (United States Biochemical Corp., Cleveland, OH) and a-[ 35S]dATP (Amersham Buchler) . As sequencing primers, the following oligonucleotides were used: L-3 ; L-4 (see above) ; L-5, 5'-TGTTGAAGGTCCTGAGT 3'; and L-6, 5'TTTGGTGGGCAATGATG-3' (28).
Results and Discussion
To identify carriers ofnondeleted AQO and BQO alleles, we determined the C4 gene structure by Southern blot analysis of Taq I-digested DNA (not shown). Four Taq I fragments can be identified with the 5'C4 probe. A 7-kb fragment usually represents a C4A gene at locus I, whereas the 6-and 5 .4-kb fragments identify long and short genes at locus II; these are usually C4 B. A 6.4-kb fragment represents a short C4B gene in combination with a deletion of the C4A gene, whereas C4B gene deletions are detected on the assessment of different intensities of the C4A-and CO-specific DNA fragments (19) . Two smaller Taq I fragments are detected with the 21-OH-specific probe. A 3.2-kb fragment represents a 21-OHA gene and a 3.7-kb fragment a 21-OHB gene (30) . All haplotypes with C4 gene deletions are listed in Table I . In 5 of 11 AQO individuals both C4A genes were deleted, whereas in 6 only one C4A gene was deleted and the other was present . 2 of 15 BQO individuals had both C4B genes deleted, 7 had one gene deleted, and in 6 neither was deleted . 10 of 16 C4A gene deletions were linked to the extended MHC haplotype HLA-Al, Cw7, B8, DR3, C4AQOB1, whereas no characteristic haplotypes were found to be linked with C4B gene deletions (Table I ). 19 individuals with 25 haplotypes carrying nondeleted null alleles, 6 AQO and 19 BQO, were selected for the study.
The antigenic determinant Ch4 is present on all C4B molecules and therefore defines the C4B isotype . Oligonucleotides (oligo A, oligo B; Fig . 1 c) , capable of distinguishing the isotype-specific Ch4 sequence at the DNA level, were used to screen nondeleted C4 null alleles . As hybridization of these oligonucleotides to genomic Southern blots did not give satisfactory results, we used PCR with subsequent oligonucleotide hybridization (Fig. 1) . A 258-bp sequence of the Cod region containing the five isotype-specific base substitutions was amplified with primers LI and L2 (Fig. 1, b-c) . Under the given hybridization conditions, the C4A and C4B isotypespecific 23-mers hybridized exclusively with the respective C4d sequence (cf., con-" -, A deletion of the respective gene . trols A and B, Fig. 1 d) . All six haplotypes carrying AQO alleles with expressed C4B genes reacted with oligos A and B. In contrast, all 19 haplotypes with BQO alleles and expressed C4A genes reacted with oligo A alone (Fig. 1 d; Table II) . Taq I fragments of 6.0 and 5.4 kb generally represent C4B genes at C4 locus II (5, 19) , but the nonhybridization of oligo B with genes at locus II suggested that C4A sequences were present. This result could also be explained by point mutations or deletions in the Ch4 sequence not detectable by Southern blot analysis. Therefore, we used RFLP analysis ofamplified DNA with Nla IV, which also distinguishes between C4A and C4B genes (reference 5; Fig. 2 a) , and confirmed that all BQO individuals revealed only C4A-specific fragments (Fig . 2 b, Table II ). In addition, the Rgl-and Chl-specific DNA sequences, which can be distinguished by RFLP analysis with EcoO 109 (5; Fig. 2 a) , also corroborated the data with oligos A and B. All six haplotypes with AQO alleles revealed both the Rgl-and Chl-specific fragments. All 19 haplotypes with BQO alleles had only the Rgl-specific fragment (Fig .  2 b, Table II ). The plasma samples of all BQO individuals were tested for the presence of Rg/Ch determinants by serology, and in accordance with the DNA data, Chl was absent from all BQO individuals (data not shown) .
The determinant Ch6, which is normally expressed by C4B but also known on C4A (14) , was assessed on the protein and the DNA level as well . Amplified DNA 
FIGURE 2. Legend on facing page .
from BQO individuals was digested with Alu I (Fig. 2, a, c) . The results were not as uniform as for the Ch4 and Chl determinants . A number of heterozygotes were detected at the DNA level (indicated by asterisk in Table II ; cf., Fig. 2 c, lanes 1,  2) , which did not allow the assignment of the Ch-6 and Ch+6 sequences to one of the haplotypes . Seven MHC haplotypes identified by linkage to HLA-B44 and Bw601acked the sequence coding for Ch6 at both C4 loci (Table II; Fig. 2 c, lanes 3, 5) . However, four haplotypes linked to HLA-B35, B39, and Bw62 had the sequence for Ch6 at both loci (Table II ; Fig. 2 c, lanes 4, 6) . Again, these findings were confirmed by serological studies: when the Ch-6 sequence was detected at Table II ), note the difference in fragment intensities between 60/70 by and 50/89 bp ; (lanes 3, 5) DNA from individuals with Ch-6 sequence; (lanes 4, 6) DNA from individuals with Ch+6 sequence ; (lanes A, B) C4A, C4B controls (cf., Fig. 1 d) .
the DNA level, the determinants Rgl and 2 were present on the C4 molecules. When the CH sequence was detected, only Rgl and Ch6 but not Rg2 were found by serology (data not shown) . This reversed antigenic association ofC4A alleles with the Ch6 determinant has already been described for several C4A allotypes (14) and thus does not contradict our previous results. For a single individual homozygous for HLA-B44, C4A3 BQO, and with four structurally intact C4 genes we directly sequenced the relevant portions of the C4d region after PCR amplification. We only detected sequences typical for the C4A isotype, i.e., Ch-4 (Fig. 3 a) , Rgl and Ch-6 (Fig. 3 b) , thus confirming our results The complete haplotype data are summarized in Table II . All six AQO alleles were found on haplotypes with HLA-Bw60 and a short C4B gene (16 kb) , as indicated by the 5.4-kb Taq I fragment (Table II A) . The DNA analysis has revealed the presence of C4A-specific sequences not detectable at the protein level by SDS PAGE, high voltage gel electrophoresis, and serology. We therefore conclude that these nondeleted genes are C4A pseudogenes on these haplotypes . The structural basis of the defect, which is not yet determined, may be due to point mutations or deletions, similar to those already observed in the 3' adjacent 21-OHA pseudogene (31, 32) . These mutations may have occurred either in the coding sequence resulting in a stop codon, or may have affected the sequences controlling the expression of the C4A gene .
We have detected only C4A-specific sequences in BQO alleles. All the haplotypes with BQO alleles had long C4 genes at both C4 loci, as defined by the 7 .0 and 6.0 kb Taq I fragments (Table II , B-C) . When C4A alleles at each locus of one haplotype are identical, the individual gene products cannot be distinguished, e.g., C4A3, (A3) BQO (Table II B) , and expression of the second locus cannot be proven . However, the expression of "converted" locus II genes is detectable when the C4A allele is different from that expressed by the accompanying C4A gene at locus I (5, 21, 22) . If expression of the converted gene can be demonstrated conclusively, then it can no longer be referred to as null allele. 6 of the 14 BQO haplotypes only expressing the C4A3 allotype carry the alleles for HLA-B44, DR4 (or DR5, DRw6) ( Table II B) . A single similar haplotype has been detected previously by using genomic RFLP analysis (5). The expression of two different CM alleles on the same haplotype can be identified only by segregation analysis in informative families. In five haplotypes, A3, A2 expression is considered probable and both genes carry C4A-specific sequences except for the Ch6 determinant (Table II C) .
Deletions and duplications of C4 genes leading to haplotypes with a single or three C4 genes have been demonstrated by RFLP studies and some of these may be due to a single unequal crossover event (18, 19) . However, gene conversion has been suggested as a mechanism for the aberrant C4A1 (Ch+) and C4B5 (Rg+) allooypps (15, 16) , which seems more acceptable than recombination by multiple crossover events . Gene conversion may be expected when two closely linked genes have arisen by duplication and have a high degree of structural homology, as is the case for the C4A and C4B genes (1, 2, 26) . Our data suggest that conversion has occurred only at locus II (C4B). Recently, however, an individual has been described with a haplotype carrying two loci (a long and a short C4 gene) both expressing C4B isotypes (C4AQO B1,5). This may serve as an example that a complete conversion at locus I (C4A) is also possible, but obviously less common (33) . As only six C4AQO haplotypes without C4A deletions were available for study and all of these are linked to HLA-Bw60, they may have arisen from a single mutation . This could also be the case for the six converted locus II genes carrying C4A-specific sequences, including the Ch-6 sequence and linked to HLA-B44. It remains to be shown, however, whether these converted genes truly express the C4A3 allotype. This can be conclusively proven only by cloning and expressing the entire gene in transfected cells, as has been demonstrated for normal human C4 genes (34) . Our approach to the study of C4 null alleles allows the rapid analysis of extensively typed individuals to further investigate the molecular basis of C4 deficiency. At the same time the C4 gene region of the MHC may serve as a model to study the complex genetic mechanism of gene conversion.
Summary
The two genes for the C4A and C4B isotypes of the fourth component of human complement are located in the MHC class III region . Previous studies have demonstrated the unusual expression of C4 genes in the form of aberrant or duplicated haplotypes. Null alleles of C4A or C4B (AQO or BQO) have been defined by the absence of gene products and occur at frequencies of 0.1-0 .3 . However, only some C4 null alleles are due to gene deletions, the remainder were thought to be nonexpressed genes. We have analyzed the C4 gene structure of 26 individuals lacking either C4A or C4B protein. The DNA of individuals with apparently nonexpressed C4 genes was tested for the presence of C4A-and C4B-specific sequences using restriction fragment analysis and isotype-specific oligonucleotide hybridization of DNA amplified by polymerase chain reaction. All nondeleted AQO alleles had C4A-specific sequences and may thus be described as pseudogenes, whereas the nondeleted BQO alleles had C4A-instead of C4B-specific sequences . Gene conversion is the probable mechanism by which a C4A gene is found at the second C4 locus normally occupied by C4B genes .
